Beam Therapeutics Inc. Long-term assets (Other)

Long-term assets (Other) of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-term assets (Other) growth rates and interactive chart. All other non-current assets that do not fit the categories above.


Highlights and Quick Summary

  • Long-term assets (Other) for the quarter ending September 30, 2022 was $14.6 Million (a -2.3% decrease compared to previous quarter)
  • Year-over-year quarterly Long-term assets (Other) increased by 1.06%
  • Annual Long-term assets (Other) for 2021 was $14.5 Million (a -19.54% decrease from previous year)
  • Annual Long-term assets (Other) for 2020 was $18 Million (a -1.77% decrease from previous year)
  • Annual Long-term assets (Other) for 2019 was $18.3 Million (a 921.08% increase from previous year)
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-term assets (Other) of Beam Therapeutics Inc.

Most recent Long-term assets (Other)of BEAM including historical data for past 10 years.

Interactive Chart of Long-term assets (Other) of Beam Therapeutics Inc.

Beam Therapeutics Inc. Long-term assets (Other) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $14.62 $14.97 $14.09
2021 $14.47 $15.89 $16.0 $19.87 $14.47
2020 $17.98 $18.39 $16.55 $16.08 $17.98
2019 $18.31 $18.31
2018 $1.79 $1.79

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology